Tenax Therapeutics CEO Chris Stern's 2011 pay slips 18% to $470K
Tenax Therapeutics reports 2011 executive compensation
By ExecPay News
Published: September 6, 2011
Tenax Therapeutics reported fiscal year 2011 executive compensation information on September 6, 2011.
In 2011, four executives at Tenax Therapeutics received on average a compensation package of $348K, a 32% decrease compared to previous year.
Average pay of disclosed executives at Tenax Therapeutics
Chris J. Stern, Chief Executive Officer, received $470K in total, which decreased by 18% compared to 2010. 64% of Stern's compensation, or $300K, was in salary. Stern also received $131K in non-equity incentive plan, $29K in stock awards, as well as $9.6K in other compensation.
Michael B. Jebsen, Chief Financial Officer, received a compensation package of $332K. 63% of the compensation package, or $210K, was in salary.
Richard Kiral, Chief Operating Officer, earned $295K in 2011, a 35% decrease compared to previous year.
Gerald Klein, Chief Medical Officer, received $294K in 2011.
Related executives
You may also like
Source: SEC filing on September 6, 2011.